DNA
Income statement / Annual
Last year (2025), Ginkgo Bioworks Holdings Inc's total revenue was $170.16 M,
a decrease of 25.06% from the previous year.
In 2025, Ginkgo Bioworks Holdings Inc's net income was -$312.76 M.
See Ginkgo Bioworks Holdings Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$170.16 M |
$227.04 M |
$251.46 M |
$477.71 M |
$313.84 M |
$76.66 M |
$54.18 M |
| Cost of Revenue |
$31.52 M
|
$38.55 M
|
$54.01 M
|
$204.22 M
|
$129.69 M
|
$15.61 M
|
$0.00
|
| Gross Profit |
$138.63 M
|
$188.49 M
|
$197.45 M
|
$273.49 M
|
$184.15 M
|
$61.05 M
|
$54.18 M
|
| Gross Profit Ratio |
0.81
|
0.83
|
0.79
|
0.57
|
0.59
|
0.8
|
1
|
| Research and Development Expenses |
$243.77 M
|
$424.06 M
|
$580.62 M
|
$1.05 B
|
$1.15 B
|
$159.77 M
|
$96.30 M
|
| General & Administrative Expenses |
$183.29 M
|
$246.16 M
|
$385.03 M
|
$1.43 B
|
$862.95 M
|
$38.31 M
|
$29.48 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$183.29 M
|
$246.16 M
|
$385.03 M
|
$1.43 B
|
$862.95 M
|
$38.31 M
|
$29.48 M
|
| Other Expenses |
$26.85 M
|
$78.03 M
|
$96.21 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$453.91 M
|
$748.25 M
|
$1.06 B
|
$2.48 B
|
$2.01 B
|
$198.07 M
|
$125.78 M
|
| Cost And Expenses |
$485.43 M
|
$786.80 M
|
$1.12 B
|
$2.69 B
|
$2.14 B
|
$213.68 M
|
$125.78 M
|
| Interest Income |
$22.62 M
|
$38.61 M
|
$57.22 M
|
$20.26 M
|
$837.00 K
|
$2.58 M
|
$5.76 M
|
| Interest Expense |
$0.00
|
$94.00 K
|
$93.00 K
|
$106.00 K
|
$2.37 M
|
$2.39 M
|
$2.42 M
|
| Depreciation & Amortization |
$58.99 M
|
$63.02 M
|
$71.55 M
|
$61.63 M
|
$29.08 M
|
$13.86 M
|
$10.76 M
|
| EBITDA |
-$254.61 M |
-$484.39 M |
-$821.29 M |
-$2.06 B |
-$1.81 B |
-$108.59 M |
-$106.66 M |
| EBITDA Ratio |
-1.5
|
-2.13
|
-3.27
|
-4.31
|
-5.76
|
-1.42
|
-1.97
|
| Operating Income Ratio |
-1.85
|
-2.47
|
-3.44
|
-4.62
|
-5.83
|
-1.79
|
-1.32
|
| Total Other Income/Expenses Net |
$1.68 M
|
$12.25 M
|
-$28.53 M
|
$87.55 M
|
-$9.66 M
|
$12.19 M
|
-$48.24 M
|
| Income Before Tax |
-$313.60 M
|
-$547.51 M
|
-$892.94 M
|
-$2.12 B
|
-$1.84 B
|
-$124.83 M
|
-$119.84 M
|
| Income Before Tax Ratio |
-1.84
|
-2.41
|
-3.55
|
-4.44
|
-5.86
|
-1.63
|
-2.21
|
| Income Tax Expense |
-$837.00 K
|
-$479.00 K
|
-$71.00 K
|
-$15.03 M
|
-$1.48 M
|
$1.89 M
|
$22.00 K
|
| Net Income |
-$312.76 M
|
-$547.03 M
|
-$892.87 M
|
-$2.10 B
|
-$1.83 B
|
-$126.61 M
|
-$119.33 M
|
| Net Income Ratio |
-1.84
|
-2.41
|
-3.55
|
-4.41
|
-5.83
|
-1.65
|
-2.2
|
| EPS |
-5.64 |
-10.54 |
-18.37 |
-50.15 |
-53.83 |
-3.97 |
-4.15 |
| EPS Diluted |
-5.64 |
-10.54 |
-18.4 |
-50.2 |
-55.53 |
-4 |
-4.15 |
| Weighted Average Shares Out |
$55.46 M
|
$51.89 M
|
$48.53 M
|
$41.93 M
|
$32.95 M
|
$31.65 M
|
$28.73 M
|
| Weighted Average Shares Out Diluted |
$55.46 M
|
$51.89 M
|
$48.61 M
|
$42.00 M
|
$34.01 M
|
$31.87 M
|
$28.73 M
|
| Link |
|
|
|
|
|
|
|
